Assessing well-being and quality of life in cancer patients during COVID-19
Well-Being and Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
This study is trying to see how the COVID-19 pandemic has affected the well-being and quality of life of cancer patients and survivors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04500600 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the well-being and health-related quality of life of cancer patients and survivors during the COVID-19 pandemic. Participants will complete an online questionnaire that explores their experiences related to COVID-19, including exposure, psychological distress, and disruptions to their health care and social interactions. The study aims to understand how these factors impact various domains of health-related quality of life and to evaluate the role of social support and resiliency in moderating these effects.
Who should consider this trial
Good fit: Ideal candidates include active cancer patients or survivors who have visited MD Anderson Cancer Center within the past five years and can communicate in English or Spanish.
Not a fit: Patients who have not been active at the center in the past five years or those who speak a language other than English or Spanish may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the specific challenges faced by cancer patients during the pandemic, leading to improved support and interventions.
How similar studies have performed: While studies on the impact of COVID-19 on various populations have been conducted, this specific focus on cancer patients' quality of life during the pandemic is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * MD Anderson active patient (visit within past 5 years) * ICD-10 confirmed cancer diagnosis * Documentation of being alive per the cancer registry * Patients who have signed consent for one of the following protocols: PA14-0241 or LAB03-0320 * Has an active email address and/or can be contacted via MyChart * English or Spanish speaker Exclusion Criteria: * Non-active patient (i.e., no visit within past 5 years) * Language other than English or Spanish * Patients who have previously consented to the following protocols: 2012-0112, 2009-0976, 2005-0035, or PA15-0336, because they will be contacted through separate IRB protocols to complete this same survey
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Lorenzo Cohen — M.D. Anderson Cancer Center
- Study coordinator: Lorenzo Cohen
- Email: lcohen@mdanderson.org
- Phone: (713) 745-4260
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.